Disease-modifying therapies are associated with improved olfactory function via NK cell- microbiota interactions in multiple sclerosis
ObjectiveTo examine the associations of nasal microbiota with disease-modifying therapies (DMTs), lymphocyte subsets and olfactory function in multiple sclerosis (MS).MethodsThirty patients with MS and 30 age- and sex-matched healthy controls (HCs) wer…